SELLAS Life Sciences Group, Inc. (SLS) stock
SLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$19.15+11.68 (+156.36%)
Close on Nov 17, 2026Market cap $3.87BP/E –Yield –
SELLAS Life Sciences price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
SELLAS Life Sciences's price to sales ratio was 29.5× on Apr 28, 2023, against 5.7× a year earlier. Over the last 2 years it ranged from 5.7× to 489.6×, with a median of 23.7×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Apr 28, 2023 | 29.5× | −19.1 |
| 2022 | Dec 30, 2022 | 48.6× | +39.3 |
| 2021 | Dec 31, 2021 | 9.2× | −466.3 |
| 2015 | Apr 30, 2015 | 475.6× | – |
See a number that looks wrong?